Zydus Lifesciences Limited (NSE: ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
964.80
-8.55 (-0.88%)
Dec 24, 2024, 3:30 PM IST

Zydus Lifesciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Operating Revenue
213,961195,474172,374151,099144,035142,531
Upgrade
Other Revenue
874-----
Upgrade
Revenue
214,835195,474172,374151,099144,035142,531
Upgrade
Revenue Growth (YoY)
14.42%13.40%14.08%4.90%1.06%8.26%
Upgrade
Cost of Revenue
63,03063,93764,70756,85749,43450,804
Upgrade
Gross Profit
151,805131,537107,66794,24294,60191,727
Upgrade
Selling, General & Admin
45,24842,45437,64832,47231,23733,066
Upgrade
Other Operating Expenses
44,23236,04734,26329,87329,29930,666
Upgrade
Operating Expenses
97,97386,14579,13969,50167,24570,709
Upgrade
Operating Income
53,83245,39228,52824,74127,35621,018
Upgrade
Interest Expense
-745-440-1,255-1,144-1,559-3,236
Upgrade
Interest & Investment Income
1,2811,281768696500330
Upgrade
Earnings From Equity Investments
1,1451,184946462474288
Upgrade
Currency Exchange Gain (Loss)
4578062,8431,482-92-92
Upgrade
Other Non Operating Income (Expenses)
403-1125162261-6
Upgrade
EBT Excluding Unusual Items
56,37348,21232,08126,85926,74018,302
Upgrade
Merger & Restructuring Charges
--177-101---442
Upgrade
Impairment of Goodwill
---5,941---454
Upgrade
Gain (Loss) on Sale of Investments
1,3851,385596874-187725
Upgrade
Gain (Loss) on Sale of Assets
134134208-17-36-147
Upgrade
Asset Writedown
-----731-2,742
Upgrade
Other Unusual Items
-316-281-1,127-1,320-
Upgrade
Pretax Income
57,57649,27326,84328,84324,46615,242
Upgrade
Income Tax Expense
13,4429,7755,8785,1171,9363,198
Upgrade
Earnings From Continuing Operations
44,13439,49820,96523,72622,53012,044
Upgrade
Earnings From Discontinued Operations
253230-4622,457-680-
Upgrade
Net Income to Company
44,38739,72820,91946,18321,85012,044
Upgrade
Minority Interest in Earnings
-1,357-1,133-1,316-1,310-514-278
Upgrade
Net Income
43,03038,59519,60344,87321,33611,766
Upgrade
Net Income to Common
43,03038,59519,60344,87321,33611,766
Upgrade
Net Income Growth
53.29%96.88%-56.31%110.32%81.34%-36.36%
Upgrade
Shares Outstanding (Basic)
1,0091,0121,0161,0241,0241,024
Upgrade
Shares Outstanding (Diluted)
1,0091,0121,0161,0241,0241,024
Upgrade
Shares Change (YoY)
-0.31%-0.37%-0.79%---
Upgrade
EPS (Basic)
42.6538.1419.3043.8320.8411.49
Upgrade
EPS (Diluted)
42.6538.1419.3043.8320.8411.49
Upgrade
EPS Growth
53.76%97.61%-55.97%110.32%81.34%-36.36%
Upgrade
Free Cash Flow
31,78323,21316,5799,01924,39920,274
Upgrade
Free Cash Flow Per Share
31.5022.9416.328.8123.8319.80
Upgrade
Dividend Per Share
-3.0006.0002.5003.5003.500
Upgrade
Dividend Growth
--50.00%140.00%-28.57%0%0%
Upgrade
Gross Margin
70.66%67.29%62.46%62.37%65.68%64.36%
Upgrade
Operating Margin
25.06%23.22%16.55%16.37%18.99%14.75%
Upgrade
Profit Margin
20.03%19.74%11.37%29.70%14.81%8.26%
Upgrade
Free Cash Flow Margin
14.79%11.88%9.62%5.97%16.94%14.22%
Upgrade
EBITDA
61,86152,57235,34431,69534,15227,602
Upgrade
EBITDA Margin
28.79%26.89%20.50%20.98%23.71%19.37%
Upgrade
D&A For EBITDA
8,0297,1806,8166,9546,7966,584
Upgrade
EBIT
53,83245,39228,52824,74127,35621,018
Upgrade
EBIT Margin
25.06%23.22%16.55%16.37%18.99%14.75%
Upgrade
Effective Tax Rate
23.35%19.84%21.90%17.74%7.91%20.98%
Upgrade
Revenue as Reported
218,090198,315174,240153,346144,491143,670
Upgrade
Advertising Expenses
-2,9572,5732,5142,5432,459
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.